Women’s Heart Health Expansion Act of 2026
Summary
The Women’s Heart Health Expansion Act of 2026 (HR7417) has been introduced in the House and referred to the Committee on Energy and Commerce. This bill authorizes $250,000,000 for fiscal years 2027 through 2031 to reauthorize and expand the WISEWOMAN program, focusing on preventive health services for women.
Key Takeaways
- 1.HR7417 authorizes $250,000,000 for the WISEWOMAN program for FY2027-2031, focusing on women's preventive heart health.
- 2.The bill is in the early stages, having been introduced and referred to the House Committee on Energy and Commerce.
- 3.Actual funding is contingent upon future appropriations, as this bill only authorizes spending ceilings.
Market Implications
The bill's authorization of $250,000,000 for preventive health services could, if appropriated, increase demand for diagnostic screenings and health education programs within the Healthcare sector. Companies involved in providing blood pressure and cholesterol screening equipment, as well as health education materials and services, could see increased opportunities. However, at this early stage, no specific publicly traded companies are directly named or implicated as primary beneficiaries. The impact on the market is currently structural, pending further legislative action and specific funding allocations.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes.
To amend Public Health Service Act to require community health centers to provide behavioral and mental health and substance use disorder services, and for other purposes.
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026